Development and optimization of hepatic cell models for pharmaco-toxicology and cell therapy research;Desarrollo, análisis y optimización de modelos celulares hepáticos para estudios de fármaco-toxicología y terapia celular

Anales de la Real Academia Nacional de Farmacia

Volumn 74, Issue 2, 2008, Pages 283-306

  Bonora Centelles, A ^a,b   Jover, R ^a,b,c   Donato, M T ^a,b,c   Lahoz, A ^b,d   Pareja, E ^a   Castell, J V ^a,c   Mir, J ^a   Gómez Lechón, Ma José ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b FIS ^*  (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d Unidad Mixta Analítica Hospital La Fe Advancell

Author keywords

Cellular transplant; Esteatosis; Hepatoblastomes; Human hepatocytes; Stem cells

Indexed keywords

CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2C9; CYTOCHROME P450 2E1; CYTOCHROME P450 3A;

ADIPOSE TISSUE CELL; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; LIVER CELL CULTURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; STEM CELL; STEM CELL TRANSPLANTATION; THEORETICAL MODEL;

EID: 49149085592     PISSN: None     EISSN: 1697428X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BELLENTANI, S. y TRIBELLI, C. (2001): The spectrum of liver disease in the general population: lesson from the Dionysos study. Physiol. Rev. 35: 531-537.
2. FISHER, R. A. y STROM, S. C. (2006): Human hepatocyte transplantation: worldwide results. Transplantation. 82: 441-449.
3. LIN, J.; SAHAKIAN, D. C.; DE MORAIS, S. M.; XU, J. J.; POLZER, R. J. y WINTER, S. M. (2003): The role of absorption, distribution, metabolism, secretion and toxicity in drug discovery. Curr. Top. Med. Chem. 3: 1125-1154.
4. GÓMEZ-LECHÓN, M. J.; DONATO, T.; PONSODA, X.; FABRA, R.; TRULLENQUE, R. y CASTELL, J. V. (1997): Isolation, culture and use of human hepatocytes in drug research. In Vitro Methods in Pharmaceutical Research. Academic Press, London, pp. 129-153.
5. MIRABET, V.; VACA, P.; CARBONELL-U BEROS, F.; MONTERO, J. A.; DALMAU, M. J.; HORNERO, F.; LEQUERICA, J. L. y PIQUER, S. (2002): Ischaemic Herat disease: searching for therapeutical solutions. In: Phillips GO, eds. World Scientific Publishing Co. Pte. Ltd., 359-374.
6. DONATO, M. T.; LAHOZ, A.; JIMÉNEZ, N.; PEREZ, G.; SERRALTA, A.; MIR, J.; CASTELL, J. V. y GÓMEZ-LECHÓN, M. J. (2006): Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts. Drug metabolism and Dispositions. 34: 1556-1562.
7. LOWRY, O. H.; ROSEBROUGH, N. J.; FARR, A. I. y RANDALL, R. J. (1951): Protein measurement with the Follin phenol reagent. J. Biol. Chem. 193: 265-275.
8. GÓMEZ-LECHÓN, M. J.; DONATO, T.; JOVER, R.; RODRÍGUEZ, C.; PONSODA, X.; CLAISE, D.; CASTELL, J. V. y GUGUEN-G UILLOUZO, C. (2001): Expression and induction of a large set of drug metabolism enzymes by the highly differentiated human hematoma cell line BC2. Eur. J. Biochem. 268: 1448-1459.
9. LAHOZ, A.; DONATO, M. T.; PICAZO, L.; GÓMEZ-LECHÓN, M. J. y CASTELL, J. V. (2007): Determination of major human cytochrome P450s activities in 96-well plates using liquid chromatography tandem mass spectrometry. Toxicol In Vitro (in press).
10. COSTA, R. H.; KALINICHENKO, V. V.; HOLTERMAN, A. X. y WANG, X. (2003): Transcription factors in liver development, differentiation, and regeneration. Hepatology. 38: 1331-1347.
11. MARTÍNEZ-JIMÉNEZ, C. P.; JOVER, R.; DONATO, T.; CASTELL, J. V y GÓMEZ- LECHÓN, M. J. (2007): CYP3A4 regulation and expression in hepatocytes. Curr. Drug. Metab. 8: 185-195.
12. DONATO, M. T.; LAHOZ, A.; JIMÉNEZ, N.; PÉREZ, G.; SERRALTA, A.; MIR, J.; CASTELL, J. V. y GÓMEZ-LECHÓN, M. J. (2006): Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts. Drug metabolism and Dispositions. 34: 1556-1562.
13. GÓMEZ-LECHÓN, M. J.; DONATO, T.; CASTELL, J. V. y JOVER, R. (2004): Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Current Drug. Metab. 5: 443-462.
14. LEKSTROM-HIMES, J. y XANTHOPOULOS, K. G. (1998): Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273: 28545-28548.
15. LI, J.; NING, G. y DUNCAN, S. A. (2000): Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev. 14: 464-474.
16. JOVER, R. (2004): Control génico de la expresión del citocromo P-450 en el hígado. En: Citocromo P-450 (Cascales-Angosto, M. y Gómez-Lechón, M. J., Eds.), pp. 205-239. Realigraf, S. A. Press, Madrid, Spain.
17. GEBHARDT, R.; HENGSTLER, J. G.; MULLER, D.; GLOCKNER, R.; BUENNING, P.; LAUBE, B.; SCHMELZER, E.; ULLRICH, M.; UTESCH, D.; HEWITT, N.; RINGEL, M.; HILZ, B. R.; BADER, A.; LANGSCH, A.; KOOSE, T.; BURGER, H. J.; MAAS, J. y OESCH, F. (2003): New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab. Rev. 35: 145-213.
18. BANAS, A.; TERATANI, T.; YAMAMOTO, Y.; TOKUHARA, M.; TAKESHITA, F.; QUINN, G.; OKOCHI, H. y OCHIYA, T. (2007): Adipose Tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 46: 219-228.
19. SEO, M. J.; SUH, S. Y.; BAE, Y. C. y JUNG, J. S. (2005): Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. BBRC. 328: 258-264.
20. SCHWARTZ, R. E.; REYES, M.; KOODIE, L.; JIANG, Y.; BLACKSTAD, M. and LUND, T. (2002): Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J. Clin. Invest. 109: 1291-1302.
21. JUNG, J.; ZHENG, M.; GOLDFARB, M. and ZARET, K. S. (1999): Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science. 284: 1998-2003.
22. ROSSI, J. M.; DUNN, N. R.; HOGAN, L. M. and ZARET, K. S. (2001): Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes & Development. 15: 1998-2009.
23. GÓMEZ-LECHÓN, M. J.; CASTELL, J.; GUILLEN, I.; O'CONNOR, E.; NAKAMURA, T.; FABRA, R. and TRULLENQUE, R. (1995): Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture. Hepatology. 21: 1248-1254.
24. MIYAJIMA, A.; KINOSHITA, T.; TANAKA, M.; KAMIYA, A.; MUKOUYAMA, Y. and HARA, T. (2000): Role of oncostatin M in hematopoyesis and liver development. Cytokines & Growth Factors Reviews. 11: 177-183.
25. HAYNESWORTH, S. E.; BABER, M. A. y CAPLAN, A. I. (1992): Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone. 13: 69-80.